KWAR23, an anti-human SIRPalpha antibody, exhibits high-affinity binding to human SIRPalpha, inhibiting its interaction with CD47. Demonstrating antitumor activity, KWAR23 is efficacious in conjunction with tumor-opsonizing antibodies, making it a valuable agent
CAS Nummer:
[2243227-60-1]
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten